D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 80 Citations 41,275 242 World Ranking 11636 National Ranking 6090

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Cardiology

Pulmonary hypertension, Internal medicine, Cardiology, Surgery and Respiratory disease are his primary areas of study. His Pulmonary hypertension study integrates concerns from other disciplines, such as Hemodynamics, Anesthesia, Blood pressure and Pulmonary artery. His studies examine the connections between Internal medicine and genetics, as well as such issues in Endocrinology, with regards to Odds ratio and Case-control study.

Stuart Rich focuses mostly in the field of Cardiology, narrowing it down to topics relating to Asymptomatic and, in certain cases, Computed tomographic, Incidence, Mass screening and Age and gender. His Surgery research includes elements of Coronary artery disease and Connective tissue disease. His Respiratory disease research is multidisciplinary, incorporating perspectives in Cancer research, Scleroderma, Disease, Survival analysis and Cohort.

His most cited work include:

  • Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry (2803 citations)
  • A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension (2191 citations)
  • PRIMARY PULMONARY HYPERTENSION: A NATIONAL PROSPECTIVE STUDY (1676 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Internal medicine, Pulmonary hypertension, Cardiology, Surgery and Hemodynamics. His work on Vasodilation, Heart failure, Prostacyclin and Ejection fraction as part of general Internal medicine study is frequently connected to In patient, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. His studies deal with areas such as Respiratory disease, Anesthesia, Intensive care medicine, Vascular resistance and Pulmonary artery as well as Pulmonary hypertension.

His work carried out in the field of Respiratory disease brings together such families of science as Chemotherapy and Pathology. Stuart Rich has researched Anesthesia in several fields, including Treprostinil and Nifedipine. The study incorporates disciplines such as Vascular disease and Blood pressure in addition to Cardiology.

He most often published in these fields:

  • Internal medicine (75.30%)
  • Pulmonary hypertension (72.47%)
  • Cardiology (60.73%)

What were the highlights of his more recent work (between 2011-2021)?

  • Internal medicine (75.30%)
  • Cardiology (60.73%)
  • Pulmonary hypertension (72.47%)

In recent papers he was focusing on the following fields of study:

Stuart Rich spends much of his time researching Internal medicine, Cardiology, Pulmonary hypertension, In patient and Heart failure. His Surgery research extends to the thematically linked field of Internal medicine. His Cardiology research integrates issues from Blood pressure and Calcium channel.

His research in Pulmonary hypertension intersects with topics in Ejection fraction, Cardiac catheterization, Cardiac output, Intensive care medicine and Levosimendan. His Heart failure study combines topics from a wide range of disciplines, such as Regurgitation, Tricuspid Valve Regurgitation and Tamponade. The various areas that Stuart Rich examines in his Pulmonary wedge pressure study include Respiratory disease and Circulatory system.

Between 2011 and 2021, his most popular works were:

  • Pulmonary arterial hypertension: epidemiology and registries (307 citations)
  • Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report. (181 citations)
  • Early Feasibility Study of a Transcatheter Tricuspid Valve Annuloplasty: SCOUT Trial 30-Day Results. (133 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Surgery
  • Cardiology

Stuart Rich mainly focuses on Pulmonary hypertension, Cardiology, Internal medicine, Heart failure and Intensive care medicine. His Pulmonary hypertension research is multidisciplinary, relying on both Exome sequencing, Wnt signaling pathway and Bioinformatics. His Cardiology study combines topics in areas such as Anesthesia, Surgery and Cohort.

His work on Hemodynamics, Pulmonary wedge pressure and Ventricular remodeling as part of general Internal medicine study is frequently linked to Pressure overload, bridging the gap between disciplines. Stuart Rich combines subjects such as Respiratory disease and Circulatory system with his study of Hemodynamics. As a part of the same scientific family, Stuart Rich mostly works in the field of Heart failure, focusing on Blood pressure and, on occasion, Atrial septostomy.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry

Gilbert E. D'Alonzo;Robyn J. Barst;Stephen M. Ayres;Edward H. Bergofsky.
Annals of Internal Medicine (1991)

4355 Citations

A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension

Robyn J. Barst;Lewis J. Rubin;Walker A. Long;Michael D. McGoon.
The New England Journal of Medicine (1996)

3228 Citations

PRIMARY PULMONARY HYPERTENSION: A NATIONAL PROSPECTIVE STUDY

S Rich;D R Dantzker;S M Ayres;E H Bergofsky.
Annals of Internal Medicine (1987)

2713 Citations

Clinical classification of pulmonary hypertension

Gerald Simonneau;Nazzareno Galiè;Lewis J Rubin;David Langleben.
Journal of the American College of Cardiology (2004)

2574 Citations

The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension.

Stuart Rich;Elizabeth Kaufmann;Paul S. Levy.
The New England Journal of Medicine (1992)

2054 Citations

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

Gerald Simonneau;Robyn J. Barst;Nazzareno Galie;Robert Naeije.
American Journal of Respiratory and Critical Care Medicine (2002)

1736 Citations

Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group

Lucien Abenhaim;Yola Moride;François Brenot;Stuart Rich.
The New England Journal of Medicine (1996)

1512 Citations

Survival in Primary Pulmonary Hypertension The Impact of Epoprostenol Therapy

Vallerie V. McLaughlin;Alicia Shillington;Stuart Rich.
Circulation (2002)

1488 Citations

Appetite-Suppressant Drugs and the Risk of Primary Pulmonary Hypertension

L. Abenhaim;Y. Moride;F. Brenot;S. Rich.
The New England Journal of Medicine (1996)

1481 Citations

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.

David B. Badesch;Victor F. Tapson;Michael D. McGoon;Bruce H. Brundage.
Annals of Internal Medicine (2000)

1387 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Stuart Rich

Marc Humbert

Marc Humbert

University of Paris-Saclay

Publications: 405

Gérald Simonneau

Gérald Simonneau

University of Paris-Saclay

Publications: 241

Olivier Sitbon

Olivier Sitbon

University of Paris-Saclay

Publications: 215

Hossein Ardeschir Ghofrani

Hossein Ardeschir Ghofrani

University of Giessen

Publications: 161

Lewis J. Rubin

Lewis J. Rubin

University of California, San Diego

Publications: 160

Werner Seeger

Werner Seeger

University of Giessen

Publications: 145

David Montani

David Montani

University of Paris-Saclay

Publications: 135

Nazzareno Galiè

Nazzareno Galiè

University of Bologna

Publications: 130

Marius M. Hoeper

Marius M. Hoeper

Hannover Medical School

Publications: 129

Horst Olschewski

Horst Olschewski

Medical University of Graz

Publications: 107

Robert Naeije

Robert Naeije

Vrije Universiteit Brussel

Publications: 107

Robyn J. Barst

Robyn J. Barst

Columbia University

Publications: 102

Matthew J. Budoff

Matthew J. Budoff

UCLA Medical Center

Publications: 96

Nicholas W. Morrell

Nicholas W. Morrell

University of Cambridge

Publications: 94

Stephen L. Archer

Stephen L. Archer

Queen's University

Publications: 94

D. Dunbar Ivy

D. Dunbar Ivy

University of Colorado Denver

Publications: 93

Trending Scientists

Chang-Su Kim

Chang-Su Kim

Korea University

Boudewijn R. Haverkort

Boudewijn R. Haverkort

Tilburg University

Adrian Kent

Adrian Kent

University of Cambridge

Huibiao Liu

Huibiao Liu

Chinese Academy of Sciences

Kazuyoshi Tanaka

Kazuyoshi Tanaka

Kyoto University

Yeng Ming Lam

Yeng Ming Lam

Nanyang Technological University

Frederick Meins

Frederick Meins

Friedrich Miescher Institute

Marco Apollonio

Marco Apollonio

University of Sassari

Roman Jerala

Roman Jerala

National Institute of Chemistry

Margaret L. Kripke

Margaret L. Kripke

The University of Texas MD Anderson Cancer Center

Terje Falck-Ytter

Terje Falck-Ytter

Uppsala University

Julia D. Grant

Julia D. Grant

Washington University in St. Louis

Ola Nilsson

Ola Nilsson

Örebro University

Michael Allon

Michael Allon

University of Alabama at Birmingham

Hilde Van Keer

Hilde Van Keer

Ghent University

Pursey P. M. A. R. Heugens

Pursey P. M. A. R. Heugens

Erasmus University Rotterdam

Something went wrong. Please try again later.